Invisible-Light Labs has successfully closed a pre-seed funding round of 1.5 million euros to accelerate its global expansion efforts. The Vienna-based deep technology company is a spin-off from TU Wien specializing in advanced infrared analysis. This financial injection will help commercialize their pioneering nanomechanical infrared analyzer while supporting new product development.
Strategic Investment and Growth
XISTA Science Ventures and aws Gründungsfonds led this significant investment round with additional participation from Fund F. The newly acquired capital will primarily drive the international market rollout of the flagship product known as EMILIE. Furthermore, the company plans to create innovative solutions tailored specifically for environmental monitoring and complex pharmaceutical applications.
Nanomaterials like aerosols and nanoplastics are becoming increasingly critical in fields ranging from environmental health to modern therapeutics. Conventional analytical methods often fail to characterize these tiny materials accurately within a reasonable timeframe. Invisible-Light Labs aims to bridge this gap by introducing a new generation of highly sensitive and user-friendly devices.
Innovative Technological Approach
The founding team combined nanoelectromechanical sensor technology with Fourier-transform infrared spectroscopy to achieve unprecedented analytical precision. This unique integration allows researchers to perform chemical analyses on materials available only in extremely minute quantities. Consequently, industries spanning from semiconductor manufacturing to environmental science can now access highly reliable nanoscale data effortlessly.
The company previously secured a substantial grant from the European Innovation Council to transition this technology from the laboratory to the market. Following its commercial launch, the flagship system earned the top innovation award from a leading analytical science magazine. A strategic partnership with Bruker Optics further expanded the global availability of this co-branded analytical system.
Scientific Validation and Impact
Recent peer-reviewed publications have strongly demonstrated the exceptional performance capabilities of this novel analytical platform. Researchers successfully identified nanoplastics in the picogram range and quantified the chemical composition of submicrometer atmospheric aerosols. These studies revealed detection limits that are approximately one thousand times lower than those of traditional analytical methods.
Company leadership emphasized that their flagship device merges the high sensitivity of nanomechanical sensors with the broad accessibility of infrared spectrometers. This funding will enable the team to bring these advanced capabilities to a much wider audience of scientific professionals. Users will range from researchers developing nanoparticle medications to atmospheric scientists working in remote polar regions.
Investor Confidence and Future Outlook
Investors expressed deep admiration for how the founding team translated robust scientific discoveries into an extraordinary commercial product. Achieving such significant milestones with limited resources highlights the exceptional focus and dedication of the entire organization. Financial backers are eager to support the enterprise as it enters this crucial next phase of technological development.
The enterprise continues to build on its strong foundation of national and international support programs to refine its offerings. By addressing major challenges in climate and health sectors, the technology promises to deliver substantial societal benefits. The ongoing collaboration with industry leaders ensures that these innovative tools will remain at the forefront of analytical science.
This successful funding round marks a pivotal moment for Invisible-Light Labs as it scales its groundbreaking analytical technology globally. The 1.5 million euros investment provides the necessary resources to revolutionize how industries analyze nanoscale materials. Ultimately, the company is well positioned to set new global standards in environmental monitoring and advanced pharmaceutical research.